Moehs Catalana, part of the Moehs Group, is a Spanish pharmaceutical leader specializing in the production of high-quality active pharmaceutical ingredients (APIs) and intermediates. Established in 1962, the company plays a critical role in the global pharmaceutical supply chain, delivering APIs for therapeutic areas such as cardiovascular, central nervous system (CNS), and anti-inflammatory treatments. Known for its stringent adherence to Good Manufacturing Practices (GMP), Moehs Catalana combines innovation with environmental responsibility, ensuring that its products meet the highest industry standards while prioritizing sustainability and regulatory compliance.